Cilcare

Cilcare is a biotechnology company founded in 2014, dedicated to reshaping the future of care by leveraging auditory science for early diagnosis and targeted treatment. Cilcare's mission is to ensure that hearing impairments are addressed earlier and more accurately, as they are often associated with chronic conditions from an early stage. As a catalyst in the development of drugs, medical devices, gene therapies, and cell therapies for treating hearing loss and tinnitus, Cilcare is driving transformative breakthroughs.